tylermenezes

You reference Kinesis in the article so I assume you've seen the Kinesis Advantage 360? I've been a happy Kinseis Advantage user for two decades, and the 360 is pretty much perfect. It has dedicated keys for activating layers, you can remap and configure on a website using web serial, and it is extremely premium looking/feeling. And of course it's very comfortable without the thumb key problem discussed in this article.

Neither.

Still happening here.

GPLv2 licenses the Wordpress code, not trademarks or the right to use Automattic's APIs.

> - The Supreme Court just stopped the deal that would have let the Sackler family, the OxyContin pushers, off the hook personally.

Paused, and is reviewing an appeal after a court approved the deal.

> - Hunter Biden's no-jail plea deal was rejected, and he goes to trial.

It wasn't really rejected, there was no deal at all. The two parties didn't have the same understanding of a key term of the deal, the judge pointed it out, and then the parties weren't able to agree on that term.

They already do require manual approval. You have to submit a support ticket before generated tokens will work.

Last I knew you could TECHNICALLY self-host everything but with little documentation on how to set it up.

There have been plenty of scaling problems (my batch, S12, has been publicly referred to a few times as "the batch that broke YC" for example).

Scaling is an iterative process :)

Goodwill impairment means, in a nutshell, they think they paid too much to acquire.

I'm not sure why they attributed this in part to pressure for job-related skills.

Everyone I've talked to who's concerned about that has been a professor at a community college (or other affordable school).

Ticketmaster has exclusive agreements with most large music venues, artists have no real choice. (I have booked large venues before.)

> When the investigators compared just the 42% of participants in the invited group who actually showed up for a colonoscopy to the control group, they saw about a 30% reduction in colon cancer risk and a 50% reduction in colon cancer death